rs147416721
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_005630.3(SLCO2A1):c.1861C>T(p.Leu621Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000701 in 1,612,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005630.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLCO2A1 | ENST00000310926.11 | c.1861C>T | p.Leu621Phe | missense_variant | Exon 14 of 14 | 1 | NM_005630.3 | ENSP00000311291.4 | ||
SLCO2A1 | ENST00000493729.5 | c.1633C>T | p.Leu545Phe | missense_variant | Exon 13 of 13 | 5 | ENSP00000418893.1 | |||
SLCO2A1 | ENST00000481359.3 | n.*423C>T | non_coding_transcript_exon_variant | Exon 13 of 13 | 5 | ENSP00000420028.3 | ||||
SLCO2A1 | ENST00000481359.3 | n.*423C>T | 3_prime_UTR_variant | Exon 13 of 13 | 5 | ENSP00000420028.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248304Hom.: 0 AF XY: 0.0000521 AC XY: 7AN XY: 134436
GnomAD4 exome AF: 0.0000698 AC: 102AN: 1460714Hom.: 0 Cov.: 30 AF XY: 0.0000619 AC XY: 45AN XY: 726686
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74308
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 621 of the SLCO2A1 protein (p.Leu621Phe). This variant is present in population databases (rs147416721, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with SLCO2A1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLCO2A1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at